[The effects of 1 alphahydroxycholecalciferol in patients with renal osteodystrophy, Paget's disease of bone and in normal subjects (author's transl)].
The administration of 1 alpha hydroxycholecalciferol (1 alpha OHD3) (2 microgr. per day) increase the plasma immunoreactive calcitonin (i CT) concentration in normal subjects after six days. This effect is also observed in patients suffering from Paget's disease of bone, suggesting that the mechanism responsable for the secretion of CT following the administration of 1 alpha is not disturbed in that disease. By contrast, the absence of increase in plasma iCT in the patients suffering from chronic renal failure suggests an impaired secretion of CT in that disorder.
D002116:Calcitonin / Q000097:blood*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood*; D006801:Humans; D006887:Hydroxycholecalciferols; D010001:Osteitis Deformans / Q000097:blood*; D012016:Reference Values
D006887:Hydroxycholecalciferols; D002116:Calcitonin
Les effets de faibles doses de 1 alpha hydroxycholecalciferol chez le sujet normal.